Literature DB >> 26045285

Successful Treatment of Refractory Majocchi's Granuloma with Voriconazole and Review of Published Literature.

H B Liu1, F Liu, Q T Kong, Y N Shen, G X Lv, W D Liu, H Sang.   

Abstract

Majocchi's granuloma (MG) is a rare deep skin dermatophyte infection that can occur either in immunocompetent or in immunocompromised individuals. Oral itraconazole or terbinafine is considered to be the first choice of treatment. We report an immunocompetent man with deep nodular form of MG, the form which is generally found in immunosuppressed individuals. Previous treatment with either oral itraconazole or terbinafine yielded no apparent improvement. After a series of examination, the man was diagnosed as having Trichophyton rubrum-induced MG mixed with bacterial infection as evidenced by growth of Klebsiella pneumoniae in tissue bacterial culture. The patient was treated with a combination of cefoselis and levofloxacin for bacterial clearance followed by voriconazole treatment. After approximately 4 months of voriconazole treatment, the lesions completely resolved. Alternative medicine (voriconazole) can be considered in case of refractory infections during MG treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26045285     DOI: 10.1007/s11046-015-9902-5

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  33 in total

1.  Majocchi’s granuloma mimicking Kaposi sarcoma in a heart transplant patient.

Authors:  Jeong-Eun Kim; Chong-Hyun Won; Sungeun Chang; Mi-Woo Lee; Jee-Ho Choi; Kee-Chan Moon
Journal:  J Dermatol       Date:  2011-09       Impact factor: 4.005

2.  Majocchi's granuloma in a 3-year-old boy.

Authors:  Wen-Wei Feng; Hsiu-Chao Chen; Hung-Chi Chen
Journal:  Pediatr Infect Dis J       Date:  2006-07       Impact factor: 2.129

3.  Majocchi's granuloma caused by Microsporum canis in an immunocompetent patient.

Authors:  V Ratajczak-Stefańska; M Kiedrowicz; R Maleszka; M Rózewicka; D Mikulska
Journal:  Clin Exp Dermatol       Date:  2009-10-12       Impact factor: 3.470

4.  Terbinafine in the treatment of Majocchi's granuloma.

Authors:  A K Gupta; R Prussick; R G Sibbald; S R Knowles
Journal:  Int J Dermatol       Date:  1995-07       Impact factor: 2.736

5.  Photo quiz. Treatment-resistant plaque on the thigh. Majocchi granuloma.

Authors:  Margaret A Collins; Rita Lloyd
Journal:  Am Fam Physician       Date:  2011-03-15       Impact factor: 3.292

6.  A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.

Authors:  R Ally; D Schürmann; W Kreisel; G Carosi; K Aguirrebengoa; B Dupont; M Hodges; P Troke; A J Romero
Journal:  Clin Infect Dis       Date:  2001-09-26       Impact factor: 9.079

Review 7.  Voriconazole : a review of its use in the management of invasive fungal infections.

Authors:  Lesley J Scott; Dene Simpson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Majocchi's granuloma of the face in an immunocompetent patient.

Authors:  Meenu Gill; Bhavna Sachdeva; Paramjeet S Gill; Brijbala Arora; Antariksh Deep; Jai Karan
Journal:  J Dermatol       Date:  2007-10       Impact factor: 4.005

9.  Tinea corporis gladiatorum presenting as a majocchi granuloma.

Authors:  Anil Kurian; Richard M Haber
Journal:  ISRN Dermatol       Date:  2011-04-12

10.  Majocchi's Granuloma after Topical Corticosteroids Therapy.

Authors:  Fu-Qiu Li; Sha Lv; Jian-Xin Xia
Journal:  Case Rep Dermatol Med       Date:  2014-10-23
View more
  5 in total

1.  Majocchi granuloma presenting as a verrucous nodule of the lip.

Authors:  Ritu Swali; Elmira Ramos-Rojas; Stephen Tyring
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-01-10

2.  Pubic Majocchi's Granuloma Unresponsive to Itraconazole Successfully Treated with Oral Terbinafine.

Authors:  Efstathios Rallis; Alexandros Katoulis; Dimitrios Rigopoulos
Journal:  Skin Appendage Disord       Date:  2015-09-03

Review 3.  Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications.

Authors:  Thomas R Rogers; Paul E Verweij; Mariana Castanheira; Eric Dannaoui; P Lewis White; Maiken Cavling Arendrup
Journal:  J Antimicrob Chemother       Date:  2022-07-28       Impact factor: 5.758

4.  Molecular Epidemiology and Antifungal Susceptibility of Trichophyton Isolates in Greece: Emergence of Terbinafine-Resistant Trichophytonmentagrophytes Type VIII Locally and Globally.

Authors:  Maria Siopi; Ioanna Efstathiou; Konstantinos Theodoropoulos; Spyros Pournaras; Joseph Meletiadis
Journal:  J Fungi (Basel)       Date:  2021-05-27

Review 5.  Majocchi's granuloma: current perspectives.

Authors:  Hazal Boral; Murat Durdu; Macit Ilkit
Journal:  Infect Drug Resist       Date:  2018-05-22       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.